![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
75
PharmaCompass offers a list of Ketorolac Trometamol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ketorolac Trometamol manufacturer or Ketorolac Trometamol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ketorolac Trometamol manufacturer or Ketorolac Trometamol supplier.
PharmaCompass also assists you with knowing the Ketorolac Trometamol API Price utilized in the formulation of products. Ketorolac Trometamol API Price is not always fixed or binding as the Ketorolac Trometamol Price is obtained through a variety of data sources. The Ketorolac Trometamol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ketorolac manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ketorolac, including repackagers and relabelers. The FDA regulates Ketorolac manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ketorolac API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ketorolac manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ketorolac supplier is an individual or a company that provides Ketorolac active pharmaceutical ingredient (API) or Ketorolac finished formulations upon request. The Ketorolac suppliers may include Ketorolac API manufacturers, exporters, distributors and traders.
click here to find a list of Ketorolac suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ketorolac DMF (Drug Master File) is a document detailing the whole manufacturing process of Ketorolac active pharmaceutical ingredient (API) in detail. Different forms of Ketorolac DMFs exist exist since differing nations have different regulations, such as Ketorolac USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ketorolac DMF submitted to regulatory agencies in the US is known as a USDMF. Ketorolac USDMF includes data on Ketorolac's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ketorolac USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ketorolac suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ketorolac Drug Master File in Korea (Ketorolac KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ketorolac. The MFDS reviews the Ketorolac KDMF as part of the drug registration process and uses the information provided in the Ketorolac KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ketorolac KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ketorolac API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ketorolac suppliers with KDMF on PharmaCompass.
A Ketorolac CEP of the European Pharmacopoeia monograph is often referred to as a Ketorolac Certificate of Suitability (COS). The purpose of a Ketorolac CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ketorolac EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ketorolac to their clients by showing that a Ketorolac CEP has been issued for it. The manufacturer submits a Ketorolac CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ketorolac CEP holder for the record. Additionally, the data presented in the Ketorolac CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ketorolac DMF.
A Ketorolac CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ketorolac CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ketorolac suppliers with CEP (COS) on PharmaCompass.
A Ketorolac written confirmation (Ketorolac WC) is an official document issued by a regulatory agency to a Ketorolac manufacturer, verifying that the manufacturing facility of a Ketorolac active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ketorolac APIs or Ketorolac finished pharmaceutical products to another nation, regulatory agencies frequently require a Ketorolac WC (written confirmation) as part of the regulatory process.
click here to find a list of Ketorolac suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ketorolac as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ketorolac API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ketorolac as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ketorolac and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ketorolac NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ketorolac suppliers with NDC on PharmaCompass.
Ketorolac Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ketorolac GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ketorolac GMP manufacturer or Ketorolac GMP API supplier for your needs.
A Ketorolac CoA (Certificate of Analysis) is a formal document that attests to Ketorolac's compliance with Ketorolac specifications and serves as a tool for batch-level quality control.
Ketorolac CoA mostly includes findings from lab analyses of a specific batch. For each Ketorolac CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ketorolac may be tested according to a variety of international standards, such as European Pharmacopoeia (Ketorolac EP), Ketorolac JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ketorolac USP).